Summary
Work History
Education
Skills
Accomplishments
Languages
Timeline
Generic

Jennifer M Arthur

Carlsbad,CA

Summary

Strategic, hands-on, Vice President with over 20 years of experience partnering with small & mid-sized pharmaceutical/biotech companies across various development and commercial stages with proven success in leading and managing teams and aligning systems with business requirements, policies and regulatory standards.

Work History

Vice President, Finance

AVALON BIOVENTURES (formerly COI PHARMACEUTICALS)
2013 - 2022

Venture firm’s life science accelerator offering early-stage companies cost-effective resources including fully functional lab and office space, in-house support, and executive teams

  • Responsible for all aspects of accounting for over 20 portfolio companies including COI Accelerator over tenure. Concurrent companies ranged from 4-12.
  • Demonstrated proficient leadership skills to motivate employees, build competent lean team, and most importantly retain them.
  • Cultivated company-wide culture of innovation and collaboration by taking best ideas / practices from leadership across portfolio companies and applying to other portfolio companies.
  • Created succession plan to provide continuity of operations during leadership transitions. As part of transition to CFO for portfolio company, recruited and trained replacement at COI, and ensured cross-training over all accounting department functions
  • Communicated business performance, forecasts and strategies to executive management and board members.
  • Collaborated with senior management to develop strategic initiatives and long term goals.
  • Established and maintained strong relationships with vendors, consultants and strategic partners.

Controller/Senior Director of Accounting

CADENCE PHARMACEUTICALS, INC
2004 - 2012

Specialty pharmaceutical company developed and commercialized Ofirmev (IV formulation of acetaminophen) acquired by Mallinkrodt in 2014

  • From company inception in 2004 responsible for building and managing accounting department to support company’s needs as it grew from small privately held company to public commercial organization
  • In 2010 Worked closely with Marketing, Sales, and HR departments as part of Commercial Launch Team - successfully on-boarded 100+ sales people in payroll and expense reporting in 1.5 months
  • Collaborated with Manufacturing and Commercial department where acted as financial representative for selection and contract review for companies 3PL in advance of commercial launch
  • Main point of contact with external auditors for quarterly reviews and annual audits
  • Significant contributor in documentation and testing effectiveness of internal controls for SOX compliance
  • Supported company’s $54 million initial public offering October 2006
  • Co-led facility selection, interior design, interim swing space and transition to new corporate headquarters (concurrent with IPO process) - Project was completed on time and within budget
  • Implemented Microsoft Dynamics (Great Plains) accounting software
  • Implemented Payroll upgrade from EasyPay to PayExpert to better suit growing public company

Director of Finance and Administration

SORRENTO ASSOCIATES
2003 - 2004

Venture Capital Firm focused on Life Sciences, High-Tech and Specialty Retail

  • Responsible for financial reporting and analysis for 6 investment funds (limited partnerships) and general partnership
  • Prepared and completed all cash and in-kind distributions to limited partners
  • Conducted capital calls
  • Monitored operating and financial performance of public and private portfolio companies
  • Oversaw NASD and SBA regulatory requirements
  • Tracked and monitored portfolio company compliance with investment agreements
  • Administration of LP database, including assignments and transfers
  • Prepared reports to limited partners, including fund update letters
  • Assisted in preparation of annual advisory council presentations as well as annual limited partner meeting presentations
  • Overall responsibility for facilities, including office space, equipment and supplies.

Controller

ANCILE PHARMACEUTICALS
2000 - 2003
  • Managed accounting related functions for start-up biotech company
  • Prepared monthly financial statements for senior management, board of directors and outside investors
  • Prepared annual operating budget
  • Computed monthly accruals for multi-site clinical trial activity
  • Grant reporting with N.I.H
  • Maintained existing accounting policies and procedures while continuously developing new internal accounting controls and procedures to increase department efficiency
  • Responsible for all human resource functions including payroll through ADP, administrating 401(k) plan, health benefits and flexible spending plan
  • Successfully coordinated move of offices and lab space including NMR machine.

Controller

NEXT PROTEINS INTERNATIONAL
1997 - 2000

Protein Supplement Wholesaler

Staff Accountant

SILBERMAN & SLOAN, LLP
1996 - 1997

Tax Accounting Firm

Accounting Consultant

VARIOUS COMPANIES
1995 - 1996

Provided consulting accounting services

Bookkeeper

COMPUTER MASTERS
1994 - 1995

Computer Value Added Reseller

Staff Accountant

PAPERNY, SHER, SHERR & COMPANY
1991 - 1994

Entertainment Industry Accounting Firm

Junior Staff Accountant

GELFAND, RENNERT AND FELDMAN
1990 - 1990

Music Division of Coopers & Lybrand - Accounting Firm

Education

Bachelor of Arts - Economics

University of California
Los Angeles

Skills

  • Financial and Risk Management
  • Process Improvement
  • Budget Oversight
  • Staff Recruiting, Development, and Retainment
  • Team Leadership - Coaching and Mentoring
  • Procedure Implementation
  • Microsoft Dynamics – Great Plains
  • SAGE – Mas90
  • QuickBooks
  • Microsoft Office 365
  • Payroll Systems: Paylocity, ADP – Pay Expert/Easy Pay
  • Concur

Accomplishments

  • Oversaw and directed accounting initiatives for 3 IPO's: Cadence (CADX -2006), Synthorx (THOR - 2018) and Janux (JANX - 2020)
  • During Avalon-Glaxo Smith Kline collaboration from 2013-2019 led accounting efforts for a 2 day close for GSK companies and all other portfolio companies within 30 days
  • As CFO for Avelas Bioscience prepared company for an IPO on AIM (Alternative Investment Market), sub-market to the London Stock Exchange. Endeavor required coordination with US/UK auditors, bankers, legal counsel and HMRC (UK Government Department The duration for this process, which typically spans at least a year, was condensed and concluded within 8 months.

Languages

English
Spanish

Timeline

Vice President, Finance

AVALON BIOVENTURES (formerly COI PHARMACEUTICALS)
2013 - 2022

Controller/Senior Director of Accounting

CADENCE PHARMACEUTICALS, INC
2004 - 2012

Director of Finance and Administration

SORRENTO ASSOCIATES
2003 - 2004

Controller

ANCILE PHARMACEUTICALS
2000 - 2003

Controller

NEXT PROTEINS INTERNATIONAL
1997 - 2000

Staff Accountant

SILBERMAN & SLOAN, LLP
1996 - 1997

Accounting Consultant

VARIOUS COMPANIES
1995 - 1996

Bookkeeper

COMPUTER MASTERS
1994 - 1995

Staff Accountant

PAPERNY, SHER, SHERR & COMPANY
1991 - 1994

Junior Staff Accountant

GELFAND, RENNERT AND FELDMAN
1990 - 1990

Bachelor of Arts - Economics

University of California
Jennifer M Arthur